Tags: asia , pharmaceuticals

M&A

As the year draws to a close, private-equity firm Actis orchestrates the sale of its portfolio company Paras Pharmaceuticals in India to Reckitt Benckiser for $726 million.

By Sameera Anand | 14 December 2010

M&A

Cardinal Health buys Yong Yu from Zuellig

US pharmaceutical distributor Cardinal Health agrees to pay $470 million for China’s largest pharmaceutical importer, Zuellig Pharma China, known locally as Yong Yu.

By Sameera Anand | 1 December 2010

M&A

Charles River buys WuXi PharmaTech in $1.6 billion deal

Pharmaceutical research company Charles River pays $1.6 billion in cash and stock to acquire Chinese outsourcing company WuXi PharmaTech two-and-a-half years after its listing ...

By Sameera Anand | 27 April 2010

Macro & Markets

Nomura forecasts a year of rebalancing for Asia

Nomura is bullish on Asia and expects that regional domestic demand will overtake exports to become the main driver of growth in 2010.

By Winnie Tang | 28 January 2010

M&A

Japan's Taisho buys select Asian assets from Bristol-Myers

Japanese firm Taisho Pharmaceutical pays $310 million for six Asia-Pacific brands and the Indonesian business of Bristol-Myers, as it seeks to build its presence in the OTC ...

By Sameera Anand | 17 September 2009

| Next »

Equities	Debt
M&A	Moves People Moves Business Moves
News & Views View Point Macro & Markets Corporate	Banking Structured Products FX Private Banking
Editor's Desk Awards Co-published Editor's Desk Polls Book Review Private Capital	Conference Highlights
Magazine Highlights

Tags: asia, pharmaceuticals

Tags: asia , pharmaceuticals